Login / Signup

Alemtuzumab as first- and second-line treatment in patients with Sézary Syndrome - the experience of a tertiary center.

Miguel NogueiraCatarina LauMaria Dos Anjos TeixeiraRita PeixeiroRenata CabralIolanda Fernandes
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • case report
  • replacement therapy
  • smoking cessation